Fig 1.
One-year (2016) period prevalence (percentage) of prolapsed nictitating membrane gland (PNMG) in dog breeds under primary veterinary care in the VetCompass™ Programme in the UK.
The horizontal bars represent 95% confidence intervals.
Table 1.
Descriptive and univariable logistic regression results for breed as a risk factor for prolapsed nictitating membrane gland (PNMG) during 2016 in dogs under primary veterinary care in the VetCompass™ Programme in the UK.
Column percentages shown in brackets.
Fig 2.
Final breed-focused mixed effects multivariable logistic regression model for risk factors associated with prolapsed nictitating membrane gland (PNMG) in dogs under primary veterinary care in the VetCompass Programme in the UK.
Clinic attended was included as a random effect. *CI confidence interval.
Table 2.
Descriptive and univariable logistic regression results for breed-derived risk factors for prolapsed nictitating membrane gland (PNMG) during 2016 in dogs under primary veterinary care in the VetCompass™ Programme in the UK.
Column percentages shown in brackets.
Table 3.
Descriptive and univariable logistic regression results for non-breed-related demographic risk factors evaluated for prolapsed nictitating membrane gland (PNMG) during 2016 in dogs under primary veterinary care in the VetCompass™ Programme in the UK.
Column percentages shown in brackets.
Fig 3.
Results for risk factors that directly replaced the breed variable in the final breed-focused mixed effects multivariable logistic regression model (along with age, sex/neuter and insurance status).
Adult (> 18 months) bodyweight (kg) replaced the breed and bodyweight relative to breed mean variables in the final breed-focused mixed effects multivariable logistic regression model. These results report associations between these risk factors and prolapsed nictitating membrane gland (PNMG) in dogs under primary veterinary care in the VetCompass™ Programme in the UK. Clinic attended was included as a random effect. *CI confidence interval.